𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic factors for T1–T2 squamous cell carcinomas of the mobile tongue: A retrospective cohort study

✍ Scribed by Laurent Bonnardot; Etienne Bardet; Olivier Steichen; Elisabeth Cassagnau; Benoit Piot; Alex P. Salam; Loïc Campion; Christophe Ferron; Claude Beauvillain de Montreuil; Olivier Malard


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
126 KB
Volume
33
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background

The aim of this study was to identify factors predicting poor prognosis at the time of early oral tongue carcinoma diagnosis.

Methods

A retrospective cohort study was carried out on 70 patients with T1 or T2 squamous cell carcinoma of the mobile tongue treated with primary surgical treatment.

Results

In all, 47% of patients received adjuvant treatment. Local recurrence was observed in 29% and regional recurrence in 26%. With a median follow‐up of 7.3 years for living patients, 5‐year actuarial overall, disease‐specific, and disease‐free survival rates were 48%, 61%, and 42%, respectively. The presence of poor histological differentiation increased the overall risk of death. Tumor thickness and posterior lingual location independently increased overall and disease‐specific risk of death. Concurrent or previous diagnosis of oral lichen significantly increased the risk of disease‐specific death and disease recurrence.

Conclusions

This study corroborates several known prognostic factors and indicates that diagnosis of oral lichen planus may be a risk factor for disease recurrence. © 2010 Wiley Periodicals, Inc. Head Neck, 2011


📜 SIMILAR VOLUMES


T1 and T2 squamous cell carcinoma of the
✍ Samuel W. Beenken; Helen Krontiras; William A. Maddox; Glenn E. Peters; Seng-jaw 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 2 views

## Background: The management of micrometastatic disease from squamous cell carcinoma (scc) of the oral tongue remains controversial. this study describes prognostic factors in the disease and reviews the role of elective neck dissection (end). ## Methods: A retrospective analysis of all patients

Evaluation of some prognostic factors in
✍ Dr. Arthur Nathanson; Karin Ågren; Anders Biörklund; Magnus G. Lind; Lars Andréa 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 479 KB 👁 1 views

In a retrospective study of 58 patients from all over Sweden, treated for small squamous cell carcinoma of the mobile tongue (T, N,M,), different prognostic factors were evaluated. A partial glossectomy was performed as primary treatment in all patients. The cancer recurred in 28 (38%) of 58 patient

Primary tumor thickness as a risk factor
✍ Carol M. Bier-Laning; Ramon Durazo-Arvizu; Kamil Muzaffar; Guy J. Petruzzelli 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

## Abstract ## Objectives/Hypothesis: Contralateral cervical metastases represent an avoidable source of failure in squamous cell carcinoma (SCCa) of the oral tongue. We sought to identify risk factors for the development of contralateral cervical metastases in T1/T2 oral tongue SCCa. ## Study De

Definitive radiotherapy for T1 and T2 sq
✍ Dr. B. Dawn Moose; Dr. Maria D. Kelly; Dr. Paul A. Levine; Dr. William C. Consta 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 448 KB 👁 2 views

## Abstract __Background.__ To assess whether survival or local control of early squamous cell carcinoma of the tonsil has been compromised by a moderate‐dose approach. __Methods.__ Between 1970 and 1989, 185 patients with SCCa of the tonsil were seen at our institution. Fifty‐three patients with

Effectiveness of routine follow-up of pa
✍ Matthias Adrianus Wilhelmus Merkx; Joris Jan Martijn van Gulick; Henri August Ma 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

## Background: The duration of follow-up after treatment for head and neck cancer, the depth of the routine visits, and the diagnostic tools used are determined on the basis of common acceptance rather than evidence-based practice. patients with early-stage tumors are more likely to benefit from fo